Database and Operations for Structured Parsing of Rare

Data Characteristics in This Category

Rare disease R&D data originates from clinical trial reports, gene sequencing data, patient records, medical literature, and drug development pipeline documents. Update frequencies vary; clinical data may update monthly or quarterly with trial progress, while medical literature is continuously published. Document structures are highly heterogeneous. Data includes structured tables (e.g., gene variation sites, patient demographics) and extensive unstructured text (e.g., symptom descriptions, treatment plans, prognosis evaluations). Fields and units in rare disease data often include specific gene nomenclature, mutation type definitions, disease phenotype codes (e.g., ORPHAcode), and specialized biomarker measurement units. These require precise identification and processing.

Constraints Imposed by These Characteristics on Database and Operations

The high heterogeneity and specificity of rare disease R&D documents challenge database design. The prevalence of semi-structured and unstructured data requires flexible schema adaptation. For example, document databases can store raw text, supplemented by relational databases for structured metadata. Dispersed data sources and varying update frequencies make data synchronization and version control critical for operations. This requires robust data ingestion pipelines and regular validation mechanisms. Specific gene nomenclature and disease coding mean data cleaning and standardization rules need high customization to ensure data consistency. Sensitive patient privacy information imposes strict requirements on data security and access control. Operations must implement fine-grained permission management and encrypted storage.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`16000`	Rare disease literature is complex; a larger context window captures full semantics.
`PARSE_FILE_TIMEOUT_SECONDS`	`600` seconds	Large files like gene sequencing reports take longer to parse; this prevents timeouts.
`Chunk size`	`800–1200` characters	Balances content completeness with model processing efficiency, reducing risk of key information truncation.
`Recall count`	Top `10` results	Ensures coverage of diverse relevant knowledge points in the rare disease domain.
`Similarity threshold`	Calibrated by actual measurement, e.g., `0.75`	Rare disease terminology is highly specific; adjust based on actual data to balance recall and precision.
`MongoDB_ReplicaSet_Name`	`rs0`	Ensures database high availability, supports primary-secondary failover, and handles load from data complexity.

Common Pitfalls

Batch processing tasks show "pending" or no progress in logs, but upstream steps completed: This usually results from insufficient concurrency configured for the batch executor, or incorrect queue_size parameter settings, leading to task accumulation.
AI-generated database queries fail with "field not found" errors: This may occur if specific rare disease fields (e.g., gene_mutation_type) are not correctly identified and mapped to the database schema during structured parsing, or if the database schema does not match expectations.
Attempts to add new database users result in insufficient permissions or connection failures: This often happens when user management commands in MongoDB are executed without switching to the admin database, or the current user lacks sufficient privileges to create new users.

How to Verify Configuration

Regularly check the data ingestion pipeline. Confirm all rare disease R&D documents from all sources are imported smoothly at the expected frequency. Record the import success rate.
Select a representative batch of rare disease clinical trial reports and gene sequencing data. Perform structured parsing. Check if key fields like gene_symbol and phenotype_code in the parsing results are accurate and consistently unitized.
Query complex questions related to a specific rare disease using the FastGPT platform. Evaluate the completeness and relevance of the retrieved results. If the results include expected key literature and data points, the configuration is effective.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.